期刊文献+

联合检测血清SCCA、CA19-9及CA125对宫颈癌诊断及预后判断的临床意义 被引量:38

Clinical significance of joint detection of serum SCCA,CA_(199),and CA_(125) for diagnosis and prognostic evaluation of cervical cancer
原文传递
导出
摘要 目的:观察联合检测血清SCCA、CA19-9和CA125水平在宫颈癌诊断及预后判断中的临床意义。方法:收集2007年1月~2011年12月收治的105例宫颈癌患者(宫颈癌组)及同期健康体检的40例妇女(对照组),分别检测血清肿瘤标志物SCCA、CA19-9和CA125水平,分析其与宫颈癌及临床分期、病理类型的关系,并观察其在初诊和复发病例中的含量差异。结果:与对照组比较,宫颈癌组血清SCCA、CA19-9和CA125含量和阳性率均显著增高,且其含量的高低与宫颈癌的临床分期密切相关;同时复发病例上述指标水平均显著高于初诊病例;SCCA在宫颈鳞癌中的水平和阳性率均显著高于宫颈腺癌,而CA19-9和CA125在宫颈鳞癌中的水平和阳性率均显著低于宫颈腺癌。结论:联合检测血清肿瘤标志物SCCA、CA19-9和CA125水平有助于宫颈癌的诊断和对其预后与病理类型的判断。 Objective: To observe the clinical significance of joint detection of serum squamous cell carcinoma antigen (SCCA) , CAI99, and CA125 for diagnosis and prognostie evaluation of cervical cancer. Methods: One hundred and five patients with cervical cancer (cervical cancer group) who were treated in the hospital from January, 2007 to December 2011 and forty women who received physical exami- nation during the same period (control group) were collected, the serum levels of SCCA, CA199 , and CA125 in the two groups were detected respectively; their relationships with cervical eancer, clinical stages, and pathological types were analyzed; the differences of the levels between patients of preliminary diagnosis and recurrent patients were observed. Results: Compared with control group, the serum contents and positive rates of SCCA, CA199, and CA12s in cervical cancer group increased significantly, and the contents were correlated with clinical sta- ges of cervical cancer; the serum contents and positive rates of SCCA, CA199, and CA125 in recurrent patients were significantly higher than those in patients of preliminary diagnosis; the serum level and positive rate of SCCA in cervical squamous cell careinoma were significantly higher than those in cervical adenocarcinoma; but tile serum levels of CA199 and CA125 in cervical squamous cell carcinoma were significantly lower than those in cervical adenocareinoma. Conclusion: Joint detection of serum SCCA, CA199 , and CA125 is conducive to diagnosis of cervical cancer and prediction of prognosis and pathological types.
作者 杨辉 郑君
出处 《中国妇幼保健》 CAS 北大核心 2013年第5期772-774,共3页 Maternal and Child Health Care of China
关键词 宫颈癌 诊断 预后 Cervical cancer Diagnosis Prognosis
  • 相关文献

参考文献10

  • 1连丽娟;林巧稚.妇科肿瘤学[M]北京:人民卫生出版社,2008288.
  • 2Hou CY,Li XL,Jiang F. Comparative evaluation of surgical stress of laparoscopically assisted vaginal radical hysterectomy and lymphadenectomy and laparotomy for early-stage cervical cancer[J].Oncol Lett,2011,(04):747.
  • 3Kucera R,Cerna M,Narsanska A. Growth factors and breast tumors,comparison of selected growth factors with traditional tumor markers[J].Anticancer Research,2011,(12):4653.
  • 4Kuroda Y,Murakami N,Morota M. Impact of concurrent chemotherapy on definitive radiotherapy for women with FIGO Ⅲb cervical cancer[J].Journal of Radiation Research,2012,(04):588.
  • 5Mabuchi S,Okazawa M,Matsuo K. Impact of histological subtype on survival of patients with surgically-treated stage IA2-(Ⅱ)B cervical cancer:Adenocarcinoma versus squamous cell carcinoma[J].Gynecologic Oncology,2012,(01):114.
  • 6Grunnet M,Sorensen JB. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer[J].Lung Cancer,2012,(02):138.
  • 7Faber TJ,Japink D,Leers MP. Activated macrophages containing tumor marker in colon carcinoma:immunohistochemical proof of a concept[J].Tumour Biology,2012,(02):435.
  • 8Poggio JL. Premalignant lesions of the anal canal and squamous cell carcinoma of the anal canal[J].Clin Colon Rectal Surg,2011,(03):177.
  • 9Ballehaninna UK,Chamberlain RS. Serum CA 19-9 as a biomarker for pancreatic cancer-a comprehensive review[J].Indian J Surg Oncol,2011,(02):88.
  • 10Xu JL,Commins J,Partridge E. Longitudinal evaluation of CA125 velocity and prediction of ovarian cancer[J].Gynecologic Oncology,2012,(01):70.

同被引文献299

引证文献38

二级引证文献257

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部